CD69 and neoplasm: Further, our findings of low expression of the early activation marker CD69 in blood but substantially higher in lymph nodes is also in agreement with a previous study demonstrating the enrichment of CD69+ lymphocytes in both tumour reactive lymph nodes and control lymph nodes [25].